|
ZNF689 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45419999997287E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.364040E-02 |
| Normal-vs-Stage2 |
2.025200E-04 |
| Normal-vs-Stage3 |
8.0941999991424E-08 |
| Normal-vs-Stage4 |
3.63809999903708E-08 |
| Stage1-vs-Stage2 |
4.351900E-02 |
| Stage1-vs-Stage3 |
7.54000000000588E-05 |
| Stage1-vs-Stage4 |
1.91213999999329E-05 |
| Stage2-vs-Stage3 |
3.399000E-01 |
| Stage2-vs-Stage4 |
1.318810E-01 |
| Stage3-vs-Stage4 |
5.088200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3975999999527E-06 |
| Normal-vs-AfricanAmerican |
2.220800E-03 |
| Normal-vs-Asian |
8.799400E-01 |
| Caucasian-vs-AfricanAmerican |
6.831000E-01 |
| Caucasian-vs-Asian |
1.412190E-01 |
| AfricanAmerican-vs-Asian |
1.682420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.3918000054185E-08 |
| Normal-vs-Female |
6.000700E-03 |
| Male-vs-Female |
7.498300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.426000E-04 |
| Normal-vs-Age(41-60Yrs) |
5.64679999999207E-05 |
| Normal-vs-Age(61-80Yrs) |
2.19699999999268E-05 |
| Normal-vs-Age(81-100Yrs) |
1.044010E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.875000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.802800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.425000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.773400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.837600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.603000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.934200E-01 |
| Normal-vs-Grade 2 |
9.701400E-03 |
| Normal-vs-Grade 3 |
7.37149999929798E-08 |
| Normal-vs-Grade 4 |
7.01989999463137E-08 |
| Grade 1-vs-Grade 2 |
1.768650E-01 |
| Grade 1-vs-Grade 3 |
1.078390E-02 |
| Grade 1-vs-Grade 4 |
2.560400E-03 |
| Grade 2-vs-Grade 3 |
8.386500E-04 |
| Grade 2-vs-Grade 4 |
7.92920000000086E-05 |
| Grade 3-vs-Grade 4 |
1.097840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.875640E-02 |
| Normal-vs-ccB subtype |
1.67267999999776E-05 |
| ccA subtype-vs-ccB subtype |
8.175400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.75760000000036E-05 |
| Normal-vs-N1 |
1.925030E-01 |
| N0-vs-N1 |
8.877200E-01 |
|
|
